Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OSTEOPOROSIS, POSTMENOPAUSAL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00489918
What this trial is testing

Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis
Zosano Pharma Corporation 165
Early research (Phase 1)Study completedNCT00769418
What this trial is testing

Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002)

Who this might be right for
Osteoporosis
Merck Sharp & Dohme LLC 62
Post-approval studies (Phase 4)Study completedNCT00551174
What this trial is testing

Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment

Who this might be right for
Post-Menopausal Osteoporosis
Hoffmann-La Roche 781
Post-approval studies (Phase 4)Study completedNCT00079924
What this trial is testing

Effects of Teriparatide in Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Eli Lilly and Company 200
Post-approval studies (Phase 4)Study completedNCT00729651
What this trial is testing

Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)

Who this might be right for
Osteoporosis Postmenopausal
Organon and Co 343
Post-approval studies (Phase 4)Ended earlyNCT00790101
What this trial is testing

Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation

Who this might be right for
Osteoporosis, Postmenopausal
Sanofi 6
Large-scale testing (Phase 3)Study completedNCT00205777
What this trial is testing

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

Who this might be right for
Osteoporosis
Pfizer 7,609
Post-approval studies (Phase 4)Study completedNCT00357331
What this trial is testing

The Effects of Potassium Citrate on Bone Metabolism

Who this might be right for
Bone Diseases, MetabolicOsteoporosis, Postmenopausal
Weill Medical College of Cornell University 83
Testing effectiveness (Phase 2)UnknownNCT01604057
What this trial is testing

Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass

Who this might be right for
OsteoporosisOsteopenia
Azelon Pharmaceuticals 130
Not applicableStudy completedNCT00659906
What this trial is testing

Optimizing Body Composition & Health After Breast Cancer

Who this might be right for
Breast NeoplasmOsteoporosis, Postmenopausal
OHSU Knight Cancer Institute 71
Not applicableStudy completedNCT04898218
What this trial is testing

Effect of Osteoanabolic Exercises on Gait, Balance & Fear of Fall Among Osteoporotic Females

Who this might be right for
Osteoporosis
Ziauddin University 93
Large-scale testing (Phase 3)Study completedNCT00048074
What this trial is testing

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

Who this might be right for
Post Menopausal Osteoporosis
Hoffmann-La Roche 1,395
Not applicableStudy completedNCT07717788
What this trial is testing

Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients

Who this might be right for
Osteoporosis, PostmenopausalStatin Therapy
Alkufa university\\collage of pharmacy 65
Testing effectiveness (Phase 2)Looking for participantsNCT07191353
What this trial is testing

Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women

Who this might be right for
HealthyOsteopeniaOsteoporosis Risk
Odense University Hospital 148
Post-approval studies (Phase 4)UnknownNCT05902078
What this trial is testing

Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis

Who this might be right for
Low Bone Mineral DensityPostmenopausal Osteoporosis
Shanghai Jiao Tong University Affiliated Sixth People's Hospital 300
Not applicableStudy completedNCT00688246
What this trial is testing

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

Who this might be right for
Breast CancerOsteoporosis
NCIC Clinical Trials Group 238
Testing effectiveness (Phase 2)Study completedNCT01992159
What this trial is testing

Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis (PMO)
Amgen 252
Not applicableStudy completedNCT05347082
What this trial is testing

Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment

Who this might be right for
Postmenopausal OsteoporosisPostmenopauseHyperparathyroidism, Secondary+2 more
Hospital Regional 1o de Octubre 47
Testing effectiveness (Phase 2)Study completedNCT00000613
What this trial is testing

CVD Risk and Health in Postmenopausal Phytoestrogen Users

Who this might be right for
Bone DiseasesCardiovascular DiseasesCoronary Disease+5 more
National Heart, Lung, and Blood Institute (NHLBI)
Post-approval studies (Phase 4)Study completedNCT06359353
What this trial is testing

Effect of Pitavastatin on Bone

Who this might be right for
Osteoporosis, OsteopeniaHypercholesterolemiaMenopausal Osteoporosis
Seoul National University Bundang Hospital 70
Next Page